American Century Companies Inc. Boosts Stake in HCA Healthcare, Inc. $HCA

American Century Companies Inc. raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 107.7% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 50,509 shares of the company’s stock after acquiring an additional 26,188 shares during the quarter. American Century Companies Inc.’s holdings in HCA Healthcare were worth $19,350,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. Park Place Capital Corp grew its stake in HCA Healthcare by 2,336.0% in the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after acquiring an additional 1,168 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of HCA Healthcare by 11.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after purchasing an additional 2,698 shares during the period. Swiss National Bank lifted its position in HCA Healthcare by 4.3% during the second quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after buying an additional 23,100 shares during the period. Cherokee Insurance Co purchased a new stake in HCA Healthcare in the 2nd quarter valued at about $3,869,000. Finally, Harrell Investment Partners LLC lifted its holdings in shares of HCA Healthcare by 176.3% during the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after acquiring an additional 1,158 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $499.59 on Wednesday. The company’s fifty day moving average price is $455.78 and its two-hundred day moving average price is $408.28. The firm has a market capitalization of $114.00 billion, a P/E ratio of 19.31, a P/E/G ratio of 1.38 and a beta of 1.36. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $520.00.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the previous year, the firm posted $4.90 earnings per share. The company’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Mizuho increased their price target on shares of HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. Zacks Research lowered HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Oppenheimer upped their price target on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. Raymond James Financial set a $525.00 price objective on HCA Healthcare in a research note on Monday, October 27th. Finally, Morgan Stanley set a $425.00 price target on shares of HCA Healthcare in a report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.